Freeline Therapeutics
$6.48
8
+$0+0% Friday 20:59
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
6MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-65.97MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow FRLN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Freeline Therapeutics Holdings plc operates as a clinical-stage systemic adeno-associated virus (AAV)-based gene therapy company. Its advanced product candidate is FLT180a, a gene therapy product candidate that is being evaluated in a Phase 1/2 dose-finding clinical trials in adult males for the treatment of patients with moderate or severe hemophilia B. The company's products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
Show more...
CEO
Employees
236
Country
US
ISIN
US35655L1070
WKN
000A2QADU
Listings
0 Comments
Share your thoughts
FAQ
What is Freeline Therapeutics stock price today?▼
The current price of FRLN is $6.48 USD — it has increased by +0% in the past 24 hours. Watch Freeline Therapeutics stock price performance more closely on the chart.
What is Freeline Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Freeline Therapeutics stocks are traded under the ticker FRLN.
What is Freeline Therapeutics revenue for the last year?▼
Freeline Therapeutics revenue for the last year amounts to 0 USD.
What is Freeline Therapeutics net income for the last year?▼
FRLN net income for the last year is -65.97M USD.
How many employees does Freeline Therapeutics have?▼
As of April 03, 2026, the company has 236 employees.
In which sector is Freeline Therapeutics located?▼
Freeline Therapeutics operates in the Manufacturing sector.
When did Freeline Therapeutics complete a stock split?▼
The last stock split for Freeline Therapeutics was on May 12, 2023 with a ratio of 1:15.
Where is Freeline Therapeutics headquartered?▼
Freeline Therapeutics is headquartered in Stevenage, US.